Corcept Therapeutics Incorporated (0I3Q.L)
| Previous close | 35.63 |
| Open | 35.39 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 34.91 - 35.84 |
| 52-week range | 20.76 - 35.84 |
| Volume | |
| Avg. volume | 2,318 |
| Market cap | 3.532B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | 0.39 |
| EPS (TTM) | 0.91 |
| Earnings date | 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireCorcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
MENLO PARK, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on July 29, 2024. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number, and a
ZacksNavigate Market Turbulence With These 4 Low-Beta Stocks
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Cool Company (CLCO), Corcept Therapeutics (CORT), TXO Partners (TXO), & JOYY (YY) are well-poised to gain.
ZacksZacks.com featured highlights include ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics
ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics have been highlighted in this Screen of The Week article.
